Ignite Creation Date:
2024-05-05 @ 9:19 PM
Last Modification Date:
2024-10-26 @ 10:02 AM
Study NCT ID:
NCT00860639
Status:
COMPLETED
Last Update Posted:
2017-01-27
First Post:
2009-03-11
Brief Title:
Efficacy of Gemtuzumab Ozogamycin for Patients Presenting an Acute Myeloid Leukemia AML With Intermediate Risk
Sponsor:
Nantes University Hospital
Organization:
Nantes University Hospital
Organization Data
Organization:
Nantes University Hospital
Class:
OTHER
Study ID:
BRD0610-I
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Nantes University Hospital
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| French Innovative Leukemia Organisation | OTHER |
| Chugai Pharmaceutical | INDUSTRY |